Successful Aortic Valve Replacement With Perceval Bioprosthesis for Aortic Stenosis With Membranous Ventricular Septum Aneurysm. Issue 2 (March 2021)

• Record Type: Journal Article
• Authors: Nishijima, Shuhei; Nakamura, Yoshitsugu; Gersak, Borut; Namiki, Shigetaka; Kouzaki, Tsunashi; Tsuchiya, Yoshiki
• Is Part Of: Innovations. Volume 16:Issue 2(2021)
• Page Start: 195
• Page End: 197
• Publication Date: 2021-03
• Subjects: aortic valve replacement -- Perceval bioprosthesis -- aortic stenosis -- membranous ventricular septum aneurysm; Cardiovascular system -- Surgery -- Periodicals; Heart -- Surgery -- Periodicals; Blood-vessels -- Surgery -- Periodicals; Chest -- Surgery -- Periodicals; Thoracic Surgical Procedures -- methods -- Periodicals; Vascular Surgical Procedures -- methods -- Periodicals; Thorax -- Chirurgie -- Méthodologie -- Périodiques; Vaisseaux sanguins -- Chirurgie -- Méthodologie -- Périodiques; Blood-vessels -- Surgery; Chest -- Surgery; Periodicals; 617.41
• DOI: 10.1177/1556984520984256
• Languages: English
• ISSNs: 1556-9845

Abstract

Membranous ventricular septum aneurysm (MVSA) is extremely rare, especially when coexisting with aortic stenosis (AS), and reports regarding the available treatment for MVSA with AS are limited. Aortic valve replacement (AVR) can be challenging because of anatomical reasons. In this case report, a patient with MVSA and severe AS was treated with AVR with the sutureless Perceval bioprosthesis. After implantation, no paravalvular leakage was detected in echocardiography, and no other postoperative complications were observed. Postoperative electrocardiography-gated computed tomography revealed no contrast enhancement for MVSA. The MVSA was closed by the Perceval bioprosthetic valve. Thus, patients with simultaneous MVSA and AS may be effectively treated with AVR using a Perceval bioprosthesis.